Diamyd Medical (Sweden) Analysis
| DMYD-B Stock | SEK 12.98 0.24 1.88% |
Diamyd Medical AB is fairly valued with Real Value of 13.32 and Hype Value of 12.98. The main objective of Diamyd Medical stock analysis is to determine its intrinsic value, which is an estimate of what Diamyd Medical AB is worth, separate from its market price. There are two main types of Diamyd Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Diamyd Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Diamyd Medical's stock to identify patterns and trends that may indicate its future price movements.
The Diamyd Medical stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Diamyd Medical's ongoing operational relationships across important fundamental and technical indicators.
Diamyd |
Diamyd Stock Analysis Notes
About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.45. Diamyd Medical AB had not issued any dividends in recent years. Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. Diamyd Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people. To learn more about Diamyd Medical AB call Ulf MBA at 46 86 61 00 26 or check out https://www.diamyd.com.Diamyd Medical AB Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Diamyd Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Diamyd Medical AB or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Diamyd Medical AB generated a negative expected return over the last 90 days | |
| The company reported the revenue of 454 K. Net Loss for the year was (118.18 M) with loss before overhead, payroll, taxes, and interest of (3.95 M). | |
| Diamyd Medical AB has accumulated about 119.76 M in cash with (93.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02. | |
| Roughly 35.0% of the company shares are held by company insiders |
Diamyd Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diamyd Medical's market, we take the total number of its shares issued and multiply it by Diamyd Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 29th of November, Diamyd Medical shows the Mean Deviation of 1.97, coefficient of variation of (849.13), and Standard Deviation of 2.74. Diamyd Medical AB technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Diamyd Medical AB Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Diamyd Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Diamyd Medical AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Diamyd Medical Outstanding Bonds
Diamyd Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Diamyd Medical AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Diamyd bonds can be classified according to their maturity, which is the date when Diamyd Medical AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Diamyd Medical Predictive Daily Indicators
Diamyd Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Diamyd Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Diamyd Medical Forecast Models
Diamyd Medical's time-series forecasting models are one of many Diamyd Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Diamyd Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Diamyd Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Diamyd Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Diamyd shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Diamyd Medical. By using and applying Diamyd Stock analysis, traders can create a robust methodology for identifying Diamyd entry and exit points for their positions.
Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. Diamyd Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Diamyd Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |